{"meta":{"query_hash":"9d7fe05d9a8b","filters":{"venue":"Journal of Gynecologic Oncology"},"cohort_total":21,"direct_labels_cover":0,"predictions_cover":21,"exported":21,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9d7fe05d9a8b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Gynecologic+Oncology"},"results":[{"id":"W1973770393","doi":"10.3802/jgo.2010.21.1.1","title":"Global cooperation in gynecologic cancer","year":2010,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cervical cancer; Breast cancer; General surgery; Cancer; Family medicine; Gynecology; Internal medicine","score_opus":0.030138176226646458,"score_gpt":0.43057934811034737,"score_spread":0.40044117188370093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973770393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94054824,0.00044144574,0.000034797922,0.010186786,0.0017826386,0.00029065795,0.000004618738,0.000012736661,0.04669805],"genre_scores_gemma":[0.9952289,0.00054741325,0.0009507277,0.0023831602,0.0006001338,0.00002476866,0.0000022209838,0.000006851696,0.00025584426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839705,0.00014527224,0.0006254579,0.0001755511,0.00027694972,0.00037972006],"domain_scores_gemma":[0.9982222,0.0004926663,0.00025604214,0.00013974014,0.0006436807,0.00024570245],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011469449,0.00012571733,0.0006165514,0.00018056425,0.00005394576,0.000015730087,0.00020493714,0.00041411672,0.016986005],"category_scores_gemma":[0.0021628446,0.000087166,0.00013000892,0.00045326655,0.00017235718,0.00010485989,0.00006641435,0.0010608713,0.00003522111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015561674,0.0014995899,0.5985895,0.000052603737,0.00008186455,0.0015979732,0.0000950347,0.00015886573,0.0057271277,0.0016285551,0.009249348,0.3797634],"study_design_scores_gemma":[0.004208037,0.0045539928,0.9176648,0.0000062315758,0.000055496697,0.00058040215,0.000090441645,0.00016826007,0.00018386671,0.0011459494,0.07125048,0.000092023045],"about_ca_topic_score_codex":0.00008845908,"about_ca_topic_score_gemma":0.009166288,"teacher_disagreement_score":0.37967137,"about_ca_system_score_codex":0.0010321194,"about_ca_system_score_gemma":0.00188863,"threshold_uncertainty_score":0.9839126},"labels":[],"label_agreement":null},{"id":"W1990608952","doi":"10.3802/jgo.2011.22.4.222","title":"ASGO's Second Biennial Meeting, November 3-5 2011","year":2011,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE","score_opus":0.05096692995109468,"score_gpt":0.3059223805317175,"score_spread":0.2549554505806228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990608952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7848535,0.0013225084,0.000033882032,0.0029545675,0.003182857,0.00029043763,0.000004177707,0.000023099486,0.20733494],"genre_scores_gemma":[0.9865686,0.00035767877,0.0085982615,0.002378557,0.00066822063,0.000016254622,0.0000011654313,0.000019573563,0.0013916496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984128,0.00011823745,0.00068389234,0.0001962667,0.00025644447,0.00033236068],"domain_scores_gemma":[0.99810845,0.00025615955,0.0007297702,0.00019658134,0.00044468886,0.00026434383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088922767,0.00017658572,0.00072869426,0.00019013278,0.000059660433,0.000007578976,0.00015393324,0.00027469333,0.025588294],"category_scores_gemma":[0.00030536254,0.00011927549,0.0002688928,0.000093309434,0.0001227868,0.00010269383,0.00005416859,0.00039538398,0.000265571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032532518,0.012542562,0.48535636,0.00013638954,0.002428226,0.014712765,0.0024776654,0.000006213779,0.0029189491,0.0021412892,0.3364865,0.13753985],"study_design_scores_gemma":[0.0066448883,0.016002836,0.58167684,0.000054257664,0.0005674683,0.002346465,0.00022938041,0.000004102103,0.0019174136,0.001070774,0.3893279,0.00015767022],"about_ca_topic_score_codex":0.00003142394,"about_ca_topic_score_gemma":0.00021442374,"teacher_disagreement_score":0.20594329,"about_ca_system_score_codex":0.00068478857,"about_ca_system_score_gemma":0.00075449474,"threshold_uncertainty_score":0.97530246},"labels":[],"label_agreement":null},{"id":"W1999009260","doi":"10.3802/jgo.2009.20.4.213","title":"KGOG's &amp; KSGOC's Symposium, Nov. 12-13, 2009","year":2009,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecologic oncology; Clinical trial; Session (web analytics); Gynecology; Oncology; Family medicine; Internal medicine","score_opus":0.03169229107742382,"score_gpt":0.33523989956274053,"score_spread":0.3035476084853167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999009260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77453977,0.0029667236,0.00018661915,0.12852716,0.0026340133,0.00064638857,0.000010649776,0.000060702532,0.09042799],"genre_scores_gemma":[0.9773944,0.0024988248,0.0062782415,0.010389875,0.0010705924,0.000011091232,0.0000071374475,0.000016551821,0.002333285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795973,0.0001440129,0.0008842997,0.00025101184,0.00031844372,0.00044251874],"domain_scores_gemma":[0.99779975,0.0004840608,0.00076268153,0.0002913942,0.00031051022,0.00035160026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069522666,0.00023956002,0.001061243,0.000262302,0.00009032805,0.00002132449,0.00017976855,0.00034674935,0.0016693017],"category_scores_gemma":[0.0003597047,0.00016562256,0.00036537868,0.00018753858,0.0000912737,0.00011558651,0.00003103169,0.000531833,0.00017765898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027798535,0.019915767,0.11238462,0.00007359855,0.0014074546,0.011081188,0.00082715834,0.00033899114,0.010143264,0.0018416203,0.43593308,0.4032734],"study_design_scores_gemma":[0.007125836,0.02482299,0.36182925,0.00007454256,0.00062975695,0.0030943106,0.00007541124,0.000008100273,0.00039001074,0.0013981895,0.6003741,0.00017747538],"about_ca_topic_score_codex":0.000012957911,"about_ca_topic_score_gemma":0.00009259317,"teacher_disagreement_score":0.40309593,"about_ca_system_score_codex":0.0010159945,"about_ca_system_score_gemma":0.0007686577,"threshold_uncertainty_score":0.9992433},"labels":[],"label_agreement":null},{"id":"W2122633766","doi":"10.3802/jgo.2015.26.4.246","title":"Wait times from diagnosis to treatment in cancer","year":2015,"lang":"en","type":"letter","venue":"Journal of Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Intensive care medicine; MEDLINE","score_opus":0.15278875397599195,"score_gpt":0.4162599657254463,"score_spread":0.26347121174945437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122633766","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18753426,0.005721196,0.000004141558,0.7974644,0.0022863767,0.00057836354,0.00007488037,0.000014840642,0.006321548],"genre_scores_gemma":[0.030066174,0.0037411964,0.0027089852,0.94934404,0.010344092,0.00030017836,0.000056533925,0.00004803783,0.0033907648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973978,0.00026717954,0.000949244,0.00033833281,0.00052261044,0.0005248406],"domain_scores_gemma":[0.99717087,0.0010612223,0.0007816831,0.00024741192,0.0004580403,0.00028077408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005121553,0.00034563834,0.001822243,0.00044166917,0.00002983944,0.00001739495,0.0003201729,0.0012415058,0.0032333878],"category_scores_gemma":[0.0008073655,0.0002373846,0.0003045006,0.00025137665,0.00006930729,0.00008039554,0.00007732765,0.0015874428,0.000120001874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039387125,0.00023386806,0.050769966,0.000014199122,0.00027828556,0.019161975,0.0002890998,0.000062817344,0.00001619532,0.0000013868383,0.879106,0.049672358],"study_design_scores_gemma":[0.0024961482,0.012888337,0.023526093,0.0002934193,0.00055786537,0.0002955345,0.00017221295,0.0000060431403,0.000050660412,0.00036477472,0.9591478,0.00020108887],"about_ca_topic_score_codex":0.0024631869,"about_ca_topic_score_gemma":0.002761347,"teacher_disagreement_score":0.15746808,"about_ca_system_score_codex":0.0074177464,"about_ca_system_score_gemma":0.0030917078,"threshold_uncertainty_score":0.9976778},"labels":[],"label_agreement":null},{"id":"W2169044620","doi":"10.3802/jgo.2012.23.2.75","title":"Three ongoing intraperitoneal chemotherapy trials in ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intraperitoneal chemotherapy; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.08828688899847667,"score_gpt":0.41027198192904546,"score_spread":0.32198509293056876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169044620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573415,0.005260262,0.00017722664,0.031074055,0.0026784996,0.00054938695,0.0000042115503,0.000010988081,0.0029038521],"genre_scores_gemma":[0.98609275,0.002967943,0.0057375557,0.0031323072,0.0019502834,0.00006227254,0.0000013096777,0.000017823802,0.000037755057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977416,0.00029929134,0.0011693441,0.00014051487,0.000205228,0.00044406534],"domain_scores_gemma":[0.99710506,0.0014959819,0.0008873751,0.00014294674,0.00012294143,0.00024567064],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038403585,0.00017372394,0.001512651,0.00025041038,0.000040468076,0.000011059247,0.00011105651,0.0002830606,0.00259286],"category_scores_gemma":[0.000885895,0.00011494507,0.0002999666,0.0002137522,0.00006943209,0.0001424178,0.000023280843,0.0004372208,0.000014517039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011300994,0.002791332,0.7337403,0.000028356018,0.0005469073,0.0004563201,0.0005953145,0.000016470327,0.0023684246,0.0005135615,0.0052489517,0.25256392],"study_design_scores_gemma":[0.011271977,0.0034853886,0.9087938,0.00009182535,0.0003329186,0.0005230305,0.00017259081,0.000010983643,0.0014518511,0.00042719423,0.07332058,0.00011785843],"about_ca_topic_score_codex":0.00010529912,"about_ca_topic_score_gemma":0.00042748087,"teacher_disagreement_score":0.2524461,"about_ca_system_score_codex":0.0014420756,"about_ca_system_score_gemma":0.0007729617,"threshold_uncertainty_score":0.9983189},"labels":[],"label_agreement":null},{"id":"W2284993392","doi":"10.3802/jgo.2015.26.4.243","title":"Who should be offered non-radical surgery for early-stage cervical cancer?","year":2015,"lang":"en","type":"letter","venue":"Journal of Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Trachelectomy; Cervical cancer; Radical Hysterectomy; Radical surgery; Stage (stratigraphy); Hysterectomy; Cancer; Lymph node; Surgery; Cervix; Parametrial; Gynecology; Internal medicine","score_opus":0.14888485793714903,"score_gpt":0.3901333814077915,"score_spread":0.2412485234706425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284993392","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057983596,0.0022671677,0.00010082891,0.9263341,0.0077121914,0.0014888116,0.0003864943,0.000045988992,0.0036808408],"genre_scores_gemma":[0.02706289,0.002234598,0.0016201367,0.9276677,0.027456785,0.00037239515,0.00029414636,0.00017419191,0.013117195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949678,0.00043471073,0.0018643969,0.0005633786,0.0011248183,0.0010448918],"domain_scores_gemma":[0.98929095,0.006588555,0.001873813,0.00039588235,0.0011761251,0.0006746684],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016264532,0.0006356863,0.004176774,0.00076442125,0.00010874443,0.000036344667,0.0005058714,0.0034133305,0.002762936],"category_scores_gemma":[0.002959009,0.00042855347,0.0014753065,0.00047121095,0.00034095216,0.00011256535,0.0001333115,0.0038195585,0.000026434604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003495237,0.00065809273,0.010366688,0.00049969566,0.0013457509,0.008133188,0.00006800033,0.000003527955,0.000024195619,0.000005474594,0.9615434,0.013856791],"study_design_scores_gemma":[0.009711343,0.011973835,0.017350568,0.0002159656,0.0018556727,0.000540698,0.00003769294,0.00001654275,0.000060381528,0.00037388323,0.95748687,0.00037655272],"about_ca_topic_score_codex":0.00020730405,"about_ca_topic_score_gemma":0.00011535352,"teacher_disagreement_score":0.030920705,"about_ca_system_score_codex":0.0032984933,"about_ca_system_score_gemma":0.0049332376,"threshold_uncertainty_score":0.99981666},"labels":[],"label_agreement":null},{"id":"W2921764825","doi":"10.3802/jgo.2019.30.e60","title":"The influence of BRCA variants of unknown significance on cancer risk management decision-making","year":2019,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University","keywords":"Medicine; Genetic testing; Logistic regression; Internal medicine; Family history; Ovarian cancer; Genetic counseling; Gynecology; Oncology; Gynecologic oncology; Cancer","score_opus":0.007597958503391047,"score_gpt":0.3094944901621453,"score_spread":0.30189653165875424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921764825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945004,0.001105593,0.00033991894,0.00020765772,0.00096951606,0.00025538987,0.000012888976,0.0000016995502,0.002606915],"genre_scores_gemma":[0.9913008,0.0041219955,0.004047453,0.00023855106,0.000094247815,0.000016820473,5.6400523e-7,0.000010541935,0.00016903417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846655,0.00021272727,0.00068345334,0.00019867574,0.00023466666,0.00020392727],"domain_scores_gemma":[0.9969554,0.0008248278,0.001407993,0.00035062892,0.00042366408,0.000037501843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010033075,0.00012262192,0.00032410075,0.00008544255,0.00007235616,0.000006888834,0.00055144436,0.00017855366,0.00009299911],"category_scores_gemma":[0.0006812972,0.000082300256,0.00013039939,0.00016765752,0.00018274852,0.000006729227,0.00013408766,0.00021444894,0.0000060159946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002952699,0.0007250427,0.10579712,0.00010459892,0.0011975855,0.000057490775,0.00026156785,0.36461043,0.12319492,0.0021571545,0.0070495955,0.39189178],"study_design_scores_gemma":[0.0033442555,0.009541013,0.80135185,0.00030211467,0.000291041,0.00006982437,0.00059324654,0.00014270506,0.025004027,0.0068450677,0.15216747,0.0003473735],"about_ca_topic_score_codex":0.0000073846895,"about_ca_topic_score_gemma":0.00007875847,"teacher_disagreement_score":0.69555473,"about_ca_system_score_codex":0.00023437428,"about_ca_system_score_gemma":0.00053329597,"threshold_uncertainty_score":0.3356107},"labels":[],"label_agreement":null},{"id":"W3024686453","doi":"10.3802/jgo.2020.31.e64","title":"Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina General Hospital","funders":"","keywords":"Medicine; Hazard ratio; Lymphadenectomy; Proportional hazards model; Stage (stratigraphy); Internal medicine; Serous fluid; Confidence interval; Hysterectomy; Serous carcinoma; Surgery; Urology; Lymph node; Oncology; Cancer; Ovarian cancer","score_opus":0.04803859510128714,"score_gpt":0.3400575573837772,"score_spread":0.29201896228249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024686453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966292,0.00011071188,0.00007501651,0.0016227233,0.0002516186,0.000648248,0.000035270878,0.000009424285,0.000617779],"genre_scores_gemma":[0.99871284,0.00008423257,0.0005774653,0.00034411126,0.00015536806,0.000031257307,0.000025589181,0.000012441104,0.000056677654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831235,0.00013807736,0.00088969385,0.00018892338,0.00022796802,0.00024299252],"domain_scores_gemma":[0.99796426,0.0006040558,0.0006785067,0.00010228344,0.00042857914,0.00022228241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002895525,0.00014884154,0.0009559097,0.00016438773,0.00002157498,0.000004439677,0.00014320147,0.00017783545,0.00021602215],"category_scores_gemma":[0.00062130124,0.000104650695,0.00021437442,0.00037867224,0.000046921818,0.000059899045,0.000045674144,0.00014629499,0.0000035931864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008468982,0.0016227745,0.9701025,0.000114145645,0.00014716944,0.00015350255,0.00013052257,0.000022666143,0.0012822342,0.000040059196,0.00008211098,0.017833326],"study_design_scores_gemma":[0.026046602,0.026095146,0.94109225,0.0000136838635,0.0001371111,0.000016183083,0.00005146106,0.000028365128,0.0014106034,0.00004401292,0.004985671,0.000078901605],"about_ca_topic_score_codex":0.00006983639,"about_ca_topic_score_gemma":0.000026941756,"teacher_disagreement_score":0.029010247,"about_ca_system_score_codex":0.0005228059,"about_ca_system_score_gemma":0.00024815748,"threshold_uncertainty_score":0.42675316},"labels":[],"label_agreement":null},{"id":"W3111661845","doi":"10.3802/jgo.2021.32.e12","title":"Time for enhancing government-led primary prevention of cervical cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Advanced Centre for Treatment, Research and Education in Cancer","keywords":"Medicine; Cervical cancer; Primary prevention; Government (linguistics); Intensive care medicine; Oncology; Cancer; Internal medicine","score_opus":0.041287247110698796,"score_gpt":0.3761330940530758,"score_spread":0.334845846942377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111661845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282559,0.001782182,0.0023936555,0.037476268,0.00060566916,0.001242912,0.000035758432,0.000021606247,0.028186018],"genre_scores_gemma":[0.99185103,0.0003599558,0.0027302217,0.003448961,0.0008438228,0.000031486714,0.0000043292644,0.000015022151,0.0007151638],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983932,0.00011096596,0.0006776838,0.00014207925,0.00043663982,0.00023946594],"domain_scores_gemma":[0.99805564,0.00073555205,0.00048657798,0.00007584248,0.00040575932,0.00024063002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006738271,0.00009722176,0.0007553326,0.000041344723,0.000033602995,0.0000041655294,0.000149661,0.00018374468,0.007840125],"category_scores_gemma":[0.0010990137,0.00007163567,0.00027732545,0.00014308823,0.00009065262,0.0000626754,0.00007388853,0.00035167378,0.000011333591],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022942198,0.0026315765,0.016369462,0.002361012,0.0010559817,0.00028491736,0.0009266262,0.00015100124,0.26524413,0.00019487746,0.027374377,0.66046387],"study_design_scores_gemma":[0.0361262,0.10353406,0.57083213,0.00019684352,0.0018179219,0.0002981037,0.0011943537,0.0021348635,0.044940434,0.0016580415,0.23680423,0.00046279185],"about_ca_topic_score_codex":0.0000033114954,"about_ca_topic_score_gemma":0.00004214311,"teacher_disagreement_score":0.66000104,"about_ca_system_score_codex":0.0008211259,"about_ca_system_score_gemma":0.0010043071,"threshold_uncertainty_score":0.99306685},"labels":[],"label_agreement":null},{"id":"W4383212587","doi":"10.3802/jgo.2023.34.e73","title":"Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Science and ICT, South Korea; National Research Foundation of Korea; National Research Foundation","keywords":"Carcinosarcoma; Medicine; Heterologous; Meta-analysis; Oncology; Internal medicine; Survival analysis; Hazard ratio; Pathology; Confidence interval; Carcinoma; Biology","score_opus":0.12949045118252145,"score_gpt":0.387482546080286,"score_spread":0.25799209489776453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383212587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023456062,0.9913846,0.000003042433,0.00073763897,0.00014773835,0.005264839,0.000061444756,0.000009395655,0.000045669294],"genre_scores_gemma":[0.023599219,0.97516257,0.0003106462,0.0003093025,0.000017197544,0.0004148784,0.000012418432,0.000031391355,0.00014236572],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922359,0.0024702447,0.004124181,0.0003833794,0.00042380768,0.00036248224],"domain_scores_gemma":[0.98709863,0.0049412907,0.006806334,0.0006421547,0.00038164604,0.00012993372],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0023894494,0.00053614494,0.01917816,0.0007528923,0.000038946742,0.000006323884,0.0005789749,0.00047960546,0.00017531861],"category_scores_gemma":[0.0031975275,0.00024278101,0.003466652,0.0016140341,0.00030083125,0.00003696819,0.00027855753,0.0007524029,0.0000060907078],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003144426,0.0014223364,0.0025885548,0.82120043,0.17156893,0.0016582432,0.000061413804,0.0000059286403,0.0000027825959,0.000020173838,0.000088944835,0.0013507981],"study_design_scores_gemma":[0.00078341574,0.004390637,0.0053376546,0.01829878,0.96694815,0.0014973592,0.00003679024,0.0000031441657,0.000001442734,0.000050336144,0.0024748023,0.0001774844],"about_ca_topic_score_codex":0.000029285156,"about_ca_topic_score_gemma":0.0001420163,"teacher_disagreement_score":0.8029017,"about_ca_system_score_codex":0.0004957506,"about_ca_system_score_gemma":0.0007718141,"threshold_uncertainty_score":0.99538314},"labels":[],"label_agreement":null},{"id":"W4386106724","doi":"10.3802/jgo.2023.34.e88","title":"Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium","year":2023,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Gynecologic cancer; Medicine; Cervical cancer; Closing (real estate); Cancer; Oncology; Internal medicine; Ovarian cancer","score_opus":0.1926091687773116,"score_gpt":0.5377957728204302,"score_spread":0.34518660404311863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386106724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.568678,0.07935863,0.000055204324,0.33846265,0.010327366,0.0019488155,0.00003686548,0.000034835335,0.0010975795],"genre_scores_gemma":[0.62061435,0.34138787,0.0011014024,0.005248747,0.027619537,0.0027119108,0.00003257693,0.00007700147,0.0012066022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99373883,0.0025528704,0.0011497868,0.0006356919,0.00072108925,0.0012017374],"domain_scores_gemma":[0.9841741,0.012793892,0.00072466955,0.00044472836,0.0015938589,0.00026876057],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009744448,0.0003063144,0.0010224935,0.0004192185,0.0010493392,0.000058480557,0.00070374086,0.00067539397,0.0008872117],"category_scores_gemma":[0.0013411117,0.00016647331,0.000228389,0.0012430823,0.0016745975,0.00019319529,0.0003260515,0.0036584274,0.000003932184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006939082,0.0024562709,0.21957783,0.0003302389,0.0009969859,0.0016244987,0.018629953,0.0008635004,0.00082557107,0.0044921935,0.27384636,0.4694175],"study_design_scores_gemma":[0.0029480087,0.003645729,0.20338085,0.0005307643,0.0002339176,0.00057761883,0.05327707,0.00047774325,0.000013172604,0.013293268,0.7213728,0.00024905577],"about_ca_topic_score_codex":0.000431745,"about_ca_topic_score_gemma":0.005905497,"teacher_disagreement_score":0.46916845,"about_ca_system_score_codex":0.0039327866,"about_ca_system_score_gemma":0.006688835,"threshold_uncertainty_score":0.9998909},"labels":[],"label_agreement":null},{"id":"W4386901193","doi":"10.3802/jgo.2023.34.e89","title":"Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium","year":2023,"lang":"en","type":"erratum","venue":"Journal of Gynecologic Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Gynecologic cancer; Closing (real estate); Cervical cancer; Cancer; Gerontology; Gynecology; Internal medicine; Ovarian cancer","score_opus":0.2155597581701038,"score_gpt":0.4348248433926212,"score_spread":0.21926508522251736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386901193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05811045,0.45819667,0.000046610025,0.29455754,0.15486674,0.0036765249,0.0012280606,0.000051386094,0.029266013],"genre_scores_gemma":[0.09439612,0.79204655,0.00025728415,0.0037428094,0.0773957,0.004546331,0.00018440792,0.0002787567,0.02715203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992307,0.001138653,0.0029340098,0.0013103101,0.00038271124,0.0019272991],"domain_scores_gemma":[0.9883846,0.005506098,0.0032627087,0.0007943395,0.0016752059,0.00037701995],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.013592491,0.0006498915,0.002342788,0.0009056689,0.001192385,0.00040827077,0.0018952349,0.0018286176,0.001144741],"category_scores_gemma":[0.0020752007,0.0004631898,0.00053396623,0.0011481089,0.0013461984,0.0004651649,0.00081915216,0.007602726,0.000023853043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005654022,0.00049188646,0.015618436,0.00021840837,0.00044629548,0.00013312763,0.003910787,0.00015537118,0.0000024276035,0.011366996,0.9322884,0.034802478],"study_design_scores_gemma":[0.0009810078,0.0010328076,0.06594419,0.0006130978,0.00011191196,0.000053552267,0.011555501,0.00022442781,3.7418903e-7,0.06343788,0.85557044,0.00047484264],"about_ca_topic_score_codex":0.0060542454,"about_ca_topic_score_gemma":0.0399687,"teacher_disagreement_score":0.33384988,"about_ca_system_score_codex":0.00783045,"about_ca_system_score_gemma":0.009621881,"threshold_uncertainty_score":0.99978197},"labels":[],"label_agreement":null},{"id":"W4387792030","doi":"10.3802/jgo.2024.35.e16","title":"Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution","year":2023,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"Gilead Sciences; London Health Sciences Foundation; Eli Lilly and Company","keywords":"Medicine; Carboplatin; Internal medicine; Endometrial cancer; Chemoradiotherapy; Radiation therapy; Oncology; Stage (stratigraphy); Cohort; Cancer; Chemotherapy; Surgery; Cisplatin","score_opus":0.07732986326666491,"score_gpt":0.39814330438218914,"score_spread":0.32081344111552423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387792030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864067,0.002907696,0.0026515864,0.0019004673,0.002141093,0.0013415227,0.00006366503,0.000048675916,0.00030464702],"genre_scores_gemma":[0.9794045,0.0047430685,0.009700496,0.00080920296,0.0012111128,0.00019962287,0.00002551695,0.000039203976,0.0038672942],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99783957,0.00023534792,0.0007629023,0.00033059905,0.00035973603,0.0004718223],"domain_scores_gemma":[0.9951271,0.0033330645,0.00078903884,0.00015183505,0.00028155072,0.00031740405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011414613,0.00027168624,0.0014263667,0.0005808903,0.00017861064,0.000020975818,0.00012374876,0.00029559564,0.00059877714],"category_scores_gemma":[0.0013376478,0.00015288641,0.0002524797,0.0008831472,0.00015219198,0.00011613544,0.000053221585,0.00028526946,0.0000027148083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17874412,0.0017274783,0.13862963,0.0004897481,0.004007093,0.0051557063,0.0013137506,0.0001930984,0.03789805,0.00011632642,0.001986748,0.6297383],"study_design_scores_gemma":[0.38561174,0.18858394,0.35487399,0.00048311148,0.004161241,0.0033020694,0.0011169495,0.00045621794,0.0077890405,0.0002457226,0.052545678,0.0008303146],"about_ca_topic_score_codex":0.000068506924,"about_ca_topic_score_gemma":0.0010743295,"teacher_disagreement_score":0.6289079,"about_ca_system_score_codex":0.0018605624,"about_ca_system_score_gemma":0.0008234708,"threshold_uncertainty_score":0.65561897},"labels":[],"label_agreement":null},{"id":"W4392835464","doi":"10.3802/jgo.2024.35.e49","title":"Simple hysterectomy <i>SHAPE-ing</i> up to be the treatment of choice for early cervical cancer under 2 cm","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Hysterectomy; Simple (philosophy); Cancer; Gynecology; Surgery; Oncology; General surgery; Internal medicine","score_opus":0.0794202515372596,"score_gpt":0.4043953162967309,"score_spread":0.32497506475947135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392835464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96567756,0.0047882716,0.00012100384,0.024709148,0.0024613894,0.0009290811,0.00005195315,0.000022259179,0.0012393164],"genre_scores_gemma":[0.99156934,0.00090261037,0.00037170763,0.0044865822,0.0011499254,0.00018644985,0.000004929418,0.000023442059,0.0013050168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839467,0.00011552733,0.0006613982,0.00022320802,0.0002626012,0.0003426179],"domain_scores_gemma":[0.995709,0.0033611802,0.0002588889,0.00016747355,0.00027405552,0.00022939358],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031865019,0.000197474,0.00085736363,0.00018667112,0.00007126289,0.000020960591,0.000178922,0.00019095391,0.0010819341],"category_scores_gemma":[0.0002837891,0.00009907174,0.00044717296,0.00043397566,0.00008037808,0.000060380688,0.000032662036,0.00019659096,0.000013549127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013835102,0.006907304,0.08432818,0.0008704136,0.008053085,0.000985334,0.006002129,0.0003428691,0.008677346,0.0014376385,0.045779146,0.82278144],"study_design_scores_gemma":[0.009463861,0.044739027,0.07332805,0.000079581136,0.0014804469,0.00013706539,0.0004570594,0.000070865,0.00205976,0.001097199,0.8669499,0.00013716627],"about_ca_topic_score_codex":0.00023213484,"about_ca_topic_score_gemma":0.00051371765,"teacher_disagreement_score":0.8226443,"about_ca_system_score_codex":0.0012519335,"about_ca_system_score_gemma":0.0006095397,"threshold_uncertainty_score":0.9998312},"labels":[],"label_agreement":null},{"id":"W4399870418","doi":"10.3802/jgo.2025.36.e5","title":"Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Vancouver Coastal Health Research Institute; Cancer Research Society","keywords":"Medicine; Disease; Ovarian carcinomas; Oncology; Ovarian cancer; Endometrial cancer; Ovarian carcinoma; Internal medicine; Cancer research; Cancer","score_opus":0.04082490073125877,"score_gpt":0.3098354617841562,"score_spread":0.26901056105289745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399870418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322855,0.0051548933,0.00028089713,0.00008057491,0.0007381381,0.00012515785,0.00000831832,0.0000031686995,0.00038027906],"genre_scores_gemma":[0.99731505,0.0003678471,0.0016971852,0.000028312008,0.0005651779,0.0000056606145,0.0000030105302,0.000010638087,0.000007125319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990439,0.00009929002,0.00044355253,0.00016938835,0.00008002379,0.00016384403],"domain_scores_gemma":[0.998676,0.0007413573,0.00026653256,0.00006793185,0.00016684968,0.000081340644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005502764,0.00009594899,0.0002547954,0.00020855007,0.000034850105,0.000020492684,0.00008358403,0.00009749546,0.000005357203],"category_scores_gemma":[0.0045819264,0.00008694667,0.000060510254,0.00025895043,0.000057791807,0.000008430827,0.000073674244,0.0001471832,2.0671702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044081916,0.00019665173,0.48241884,0.00016552403,0.00011311653,0.0005772864,0.0002457672,0.0024498864,0.477473,0.00029564748,0.00010491741,0.035518557],"study_design_scores_gemma":[0.0037479186,0.0058356356,0.91514766,0.00027330287,0.00022696481,0.00042006234,0.0007350164,0.0025085846,0.06332369,0.002945418,0.004481705,0.00035402697],"about_ca_topic_score_codex":0.000023736942,"about_ca_topic_score_gemma":0.00002743197,"teacher_disagreement_score":0.43272883,"about_ca_system_score_codex":0.00015071942,"about_ca_system_score_gemma":0.0007105534,"threshold_uncertainty_score":0.5485325},"labels":[],"label_agreement":null},{"id":"W4403745530","doi":"10.3802/jgo.2024.35.e117","title":"Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Queen's University; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Hysterectomy; Cervical cancer; Radical Hysterectomy; Clinical trial; Oncology; Gynecology; Urology; Cancer; Surgery; Internal medicine","score_opus":0.09709792608531605,"score_gpt":0.42203080751843247,"score_spread":0.32493288143311644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403745530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892045,0.0017399131,0.0019450583,0.0029610146,0.001590978,0.0022025728,0.000424096,0.000031272695,0.0001846422],"genre_scores_gemma":[0.9968669,0.000112375754,0.0007645315,0.0007509705,0.00094091275,0.00040689704,0.00009214079,0.000023187553,0.00004210431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608487,0.0009329613,0.0014351838,0.0004888915,0.0005849474,0.00047317392],"domain_scores_gemma":[0.9846074,0.0134955235,0.000636815,0.00033872252,0.0005234455,0.00039808702],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016098234,0.000319073,0.0030805627,0.0011550046,0.00010710249,0.000054597214,0.00044211428,0.00034047355,0.0023575523],"category_scores_gemma":[0.0011962452,0.00018244675,0.0020138423,0.0046026134,0.00016509862,0.00009627131,0.000105642954,0.00051403505,0.000011565982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22651722,0.0041764136,0.42862594,0.00032146805,0.14611156,0.0007883573,0.0015066579,0.0026335954,0.0021564031,0.000137385,0.00258251,0.18444248],"study_design_scores_gemma":[0.061833564,0.016142888,0.81071246,0.00011703437,0.07444875,0.00002001017,0.00029883016,0.0038688984,0.00055185874,0.0004080969,0.03132627,0.00027136595],"about_ca_topic_score_codex":0.001123593,"about_ca_topic_score_gemma":0.001696799,"teacher_disagreement_score":0.3820865,"about_ca_system_score_codex":0.0013085733,"about_ca_system_score_gemma":0.0007484756,"threshold_uncertainty_score":0.9985544},"labels":[],"label_agreement":null},{"id":"W4405616616","doi":"10.3802/jgo.2025.36.e51","title":"Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Research Foundation of Korea; Medical Research Council; PharmaMar; Eisai; Amgen; National University of Singapore; National Research Foundation; Chugai Pharmaceutical; Seagen; MacroGenics; Sierra Oncology; Incyte; BeiGene; Clovis Oncology; AstraZeneca; Novocure; Ministry of Science and ICT, South Korea; Kimberly-Clark; Regeneron Pharmaceuticals; Mersana Therapeutics; National Medical Research Council; Karyopharm Therapeutics; Sanofi; GlaxoSmithKline","keywords":"Medicine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Carcinoma; Phases of clinical research","score_opus":0.03196311436663559,"score_gpt":0.3535288015074919,"score_spread":0.3215656871408563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405616616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886238,0.00180299,0.00003568188,0.0032833936,0.0016211953,0.0026560784,0.000016637256,0.000029242796,0.0019309713],"genre_scores_gemma":[0.9959693,0.0010551091,0.0019844892,0.00028552866,0.00028595264,0.00019480857,0.000009318312,0.00004575661,0.00016972721],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99573666,0.0006689004,0.0018703697,0.00056864735,0.00057641714,0.00057898276],"domain_scores_gemma":[0.9934542,0.0045686592,0.0010107994,0.00035471085,0.00032849138,0.00028312296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019660585,0.00047531814,0.0030440462,0.00056769897,0.00010519535,0.000029614184,0.0002742818,0.00039025018,0.002129412],"category_scores_gemma":[0.0006031982,0.00026637092,0.00041972133,0.00065069285,0.00026084043,0.00014539709,0.00010518055,0.0010098331,0.00001519803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77415216,0.07127146,0.0058044577,0.00025390607,0.001912549,0.01706167,0.005304331,0.000114401504,0.0005331011,0.000049525403,0.002326395,0.12121605],"study_design_scores_gemma":[0.64240843,0.33044332,0.017075835,0.00014370221,0.0016041294,0.00041053575,0.0028246925,0.000510876,0.0006758289,0.000052105548,0.0035888262,0.00026170994],"about_ca_topic_score_codex":0.00008710583,"about_ca_topic_score_gemma":0.0005067054,"teacher_disagreement_score":0.25917187,"about_ca_system_score_codex":0.0017411418,"about_ca_system_score_gemma":0.0014813766,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W4408009970","doi":"10.3802/jgo.2025.36.e60","title":"Cognitive deficit identified via pre-operative patient reported outcome measures is a predictor for post-operative health care utilization in gynecologic oncology patients","year":2025,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Cognition; Health care; Outcome (game theory); MEDLINE; Gynecologic cancer; Intensive care medicine; Patient-reported outcome; Oncology; Internal medicine; Emergency medicine; Cancer; Psychiatry; Quality of life (healthcare); Nursing; Ovarian cancer","score_opus":0.056354974420547974,"score_gpt":0.406434012427294,"score_spread":0.350079038006746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408009970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739695,0.0012766124,0.003975611,0.008353512,0.002695845,0.0062659453,0.00021964424,0.000047910697,0.0031954192],"genre_scores_gemma":[0.9420515,0.00019286881,0.0009865352,0.055689223,0.00007179989,0.00040685898,0.000338732,0.00004030327,0.00022222259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933675,0.0014952995,0.0030306343,0.00074326753,0.0005378939,0.00082539057],"domain_scores_gemma":[0.95951,0.0034788845,0.0024980234,0.000249887,0.033988833,0.00027436542],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00131645,0.00055156276,0.0022672664,0.0013191578,0.0003241971,0.00003297292,0.00025495517,0.000833543,0.0002524054],"category_scores_gemma":[0.051872898,0.00044360178,0.00051030336,0.0007686242,0.0004295572,0.00026043467,0.00015724909,0.0011666006,0.000009872402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02214774,0.008563697,0.66864353,0.00060313684,0.0027049242,0.001253904,0.042863097,0.0001093154,0.0012840881,0.00024924445,0.015303215,0.2362741],"study_design_scores_gemma":[0.0264168,0.077810846,0.7849934,0.00055198366,0.001152957,0.00020908439,0.09706333,0.00016035174,0.0014747742,0.00046364227,0.0091715995,0.0005312369],"about_ca_topic_score_codex":0.000078671976,"about_ca_topic_score_gemma":0.0014187447,"teacher_disagreement_score":0.23574285,"about_ca_system_score_codex":0.0052919756,"about_ca_system_score_gemma":0.0051118643,"threshold_uncertainty_score":0.9998016},"labels":[],"label_agreement":null},{"id":"W4408493341","doi":"10.3802/jgo.2025.36.e85","title":"A decade data of HPV genotypes in metropolitan regions of Indonesia: paving the way for a national cervical cancer elimination strategy","year":2025,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Fakultas Kedokteran, Universitas Indonesia; Universitas Indonesia","keywords":"Medicine; Cervical cancer; Genotype; Metropolitan area; Cancer; Oncology; Gynecology; Virology; Internal medicine; Genetics; Pathology; Gene","score_opus":0.12816202023017248,"score_gpt":0.46550193388578875,"score_spread":0.3373399136556163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408493341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8500999,0.009183672,0.0029475836,0.09358563,0.0007990276,0.0017854715,0.00020950484,0.000011358634,0.04137784],"genre_scores_gemma":[0.9979756,0.0005277863,0.0007396114,0.00046295518,0.00014987236,0.000029328447,0.000010417201,0.0000050982485,0.00009937159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843216,0.00019361541,0.00071895315,0.0001430633,0.00030816952,0.00020405297],"domain_scores_gemma":[0.9956171,0.0025974035,0.0004063352,0.00017831684,0.0011436614,0.00005719075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017129974,0.0000802312,0.00052343495,0.00038495025,0.000049031732,0.0000048796874,0.00040910344,0.00019280452,0.0006784458],"category_scores_gemma":[0.0022590894,0.0000499471,0.00010280725,0.00049162476,0.00020427014,0.00007643238,0.00013269407,0.0004145407,2.674213e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009293041,0.0040090284,0.16658129,0.0017116696,0.0012586586,0.000094796844,0.0006376077,0.00048391818,0.0075781285,0.1633721,0.021087462,0.6238923],"study_design_scores_gemma":[0.003106635,0.0020566715,0.9781204,0.000029478759,0.00016950264,0.00003063106,0.0010588949,0.00075882464,0.00048935006,0.009762455,0.0043741656,0.000043002903],"about_ca_topic_score_codex":0.00013919239,"about_ca_topic_score_gemma":0.0033228365,"teacher_disagreement_score":0.8115391,"about_ca_system_score_codex":0.0010090194,"about_ca_system_score_gemma":0.0023820545,"threshold_uncertainty_score":0.7428506},"labels":[],"label_agreement":null},{"id":"W4408678810","doi":"10.3802/jgo.2025.36.e74","title":"FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Positive Living North; Spinal Cord Injury BC; University of Northern British Columbia; University of Calgary; University of British Columbia","funders":"National Cancer Institute; Janet D. Cottrelle Foundation; BC Cancer Foundation; Ovarian Cancer Canada; Alberta Precision Laboratories; VGH and UBC Hospital Foundation; Cancer Research Society","keywords":"Medicine; Ovarian carcinoma; Carcinoma; Oncology; Serous carcinoma; Serous fluid; Internal medicine; Cancer research; Ovarian cancer; Gynecology; Cancer","score_opus":0.013680263308538075,"score_gpt":0.3049934721474857,"score_spread":0.2913132088389476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408678810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718464,0.0054194,0.00021940283,0.005049488,0.00051882584,0.00067667424,0.00003102705,0.000014145401,0.00088640075],"genre_scores_gemma":[0.9966771,0.00022280678,0.0016465632,0.0011758091,0.00007672019,0.000053687356,0.000010663223,0.000028801323,0.000107844375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713385,0.00047284935,0.0011311992,0.00044167147,0.00029218924,0.0005282203],"domain_scores_gemma":[0.9976782,0.00068209035,0.00077384023,0.00037842532,0.0002739378,0.00021350267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072728645,0.00036082946,0.0013531428,0.0003997847,0.00010803157,0.000022599166,0.000248304,0.0004813517,0.00017257563],"category_scores_gemma":[0.00022153658,0.000275864,0.0002197869,0.00033958428,0.00019071186,0.00010270065,0.00013590812,0.0005972503,0.0000018531109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027350932,0.0018651695,0.9444644,0.00036889562,0.00030421224,0.0066332566,0.0015870073,0.000036812467,0.036694016,0.0011342093,0.00020584874,0.0039711203],"study_design_scores_gemma":[0.009805447,0.007975565,0.9461514,0.00031150976,0.00035358092,0.0004455468,0.00096077373,0.000054763765,0.030162022,0.0020253265,0.0015439875,0.00021008043],"about_ca_topic_score_codex":0.0007105964,"about_ca_topic_score_gemma":0.00056844513,"teacher_disagreement_score":0.009492469,"about_ca_system_score_codex":0.0011989981,"about_ca_system_score_gemma":0.0013221219,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4413453280","doi":"10.3802/jgo.2026.37.e9","title":"Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification","year":2025,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ministry of Health and Welfare","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Homologous recombination; Toxicity; Homologous chromosome; Oncology; Poly ADP ribose polymerase; Internal medicine; Cancer; Pharmacology; Genetics; DNA; Polymerase; Gene","score_opus":0.01131643990735361,"score_gpt":0.3096241683581557,"score_spread":0.2983077284508021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413453280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941912,0.0010880432,0.00012621241,0.0027173874,0.00036002483,0.0007798347,0.000009871867,0.000006303516,0.0007210941],"genre_scores_gemma":[0.9980772,0.0005844942,0.0009019298,0.00031616815,0.000025377622,0.000060877326,0.0000039711276,0.0000072663265,0.00002272639],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831283,0.00026410358,0.0008449636,0.00017446991,0.00022549577,0.00017813417],"domain_scores_gemma":[0.9966682,0.0013796333,0.0011196659,0.00018582192,0.00058982224,0.00005685709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000620727,0.00013030654,0.00060947536,0.00029882736,0.000054619548,0.000004872921,0.00014651152,0.00017376013,0.0000561435],"category_scores_gemma":[0.0006907866,0.00008405009,0.00006229619,0.0004416732,0.00026028097,0.000082870465,0.000030072493,0.00033623894,3.3044802e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013032837,0.008685998,0.36966923,0.00015328918,0.00035982596,0.000054181382,0.0022532537,0.0035537404,0.047685504,0.0028225011,0.00054548716,0.5511842],"study_design_scores_gemma":[0.029801365,0.0113570895,0.93932927,0.00030400988,0.00015003124,0.00002044109,0.0005797789,0.00013671257,0.012576667,0.0045263697,0.0011152899,0.000102996586],"about_ca_topic_score_codex":0.000051667692,"about_ca_topic_score_gemma":0.00012556245,"teacher_disagreement_score":0.56966,"about_ca_system_score_codex":0.00054692547,"about_ca_system_score_gemma":0.0007840034,"threshold_uncertainty_score":0.34274632},"labels":[],"label_agreement":null}]}